<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <titles>
      <item>
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Animal Generic Drug User Fee Amendments of 2013</title>
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to generic new animal drugs.</title>
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>Animal Generic Drug User Fee Amendments of 2013</title>
        <chamberName />
      </item>
    </titles>
    <introducedDate>2013-04-09</introducedDate>
    <notes>
      <item>
        <links />
        <text><![CDATA[For further action, see S.622, which became Public Law 113-14 on 6/13/2013.]]></text>
      </item>
    </notes>
    <calendarNumbers />
    <committees>
      <billCommittees>
        <item>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2013-04-12T20:03:13Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2013-04-09T18:01:15Z</date>
            </item>
          </activities>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <lastName>Gardner</lastName>
        <middleName />
        <bioguideId>G000562</bioguideId>
        <firstName>Cory</firstName>
        <byRequestType />
        <fullName>Rep. Gardner, Cory [R-CO-4]</fullName>
        <identifiers>
          <bioguideId>G000562</bioguideId>
          <lisID>1998</lisID>
          <gpoId>7862</gpoId>
        </identifiers>
      </item>
    </sponsors>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Animal and plant health</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>User charges and fees</name>
          </item>
          <item>
            <name>Veterinary medicine and animal diseases</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <originChamber>House</originChamber>
    <createDate>2013-04-11T09:40:12Z</createDate>
    <congress>113</congress>
    <recordedVotes />
    <billType>HR</billType>
    <actions>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2013-04-12</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <actionDate>2013-04-09</actionDate>
        <links />
        <actionCode>H11100</actionCode>
      </item>
      <item>
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <actionDate>2013-04-09</actionDate>
        <links />
        <actionCode>Intro-H</actionCode>
      </item>
      <item>
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <actionDate>2013-04-09</actionDate>
        <links />
        <actionCode>1000</actionCode>
      </item>
    </actions>
    <summaries>
      <billSummaries>
        <item>
          <actionDesc>Introduced in House</actionDesc>
          <actionDate>2013-04-09</actionDate>
          <updateDate>2013-04-09T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <lastSummaryUpdateDate>2013-06-21T17:27:17Z</lastSummaryUpdateDate>
          <name>Introduced in House</name>
          <text><![CDATA[<p>Animal Generic Drug User Fee Amendments of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to extend for FY2014-FY2018 the authority of the Food and Drug Administration (FDA) to collect generic animal drug user fees, specifically abbreviated application fees for generic new animal drugs, generic new animal drug product fees, and generic new animal drug sponsor fees.</p> <p>Subjects generic animal drug applications to a fee 50% of the amount of the normal fee if the application is for an animal drug which contains more than one active ingredient, or the labeling of the drug prescribes, recommends, or suggests use of the drug in combination with one or more other animal drugs, and the active ingredients or drugs intended for use in the combination have previously been separately approved.</p> <p>Revises the due date for annual generic animal drug user fees to the later of January 31 of each year or the first business day after enactment of an appropriations act providing for the collection and obligation of fees for the fiscal year.</p> <p>Establishes the total amount of revenue each type of generic user fee shall generate.</p> <p>Authorizes the Secretary of Health and Human Services (HHS) to accept payment of user fees prior to their due date.</p> <p> Extends requirements for the FDA to report to Congress on achieving goals related to the generic animal drug development and review process and the implementation of the authority to collect generic animal drug fees.</p> <p>Terminates the authority to collect generic animal drug user fees October 1, 2018.</p>]]></text>
        </item>
      </billSummaries>
    </summaries>
    <constitutionalAuthorityStatementText><![CDATA[<pre>By Mr. GARDNER:H.R. 1408.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 of the United StatesConstitution.[Page H1858]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills>
      <item>
        <number>622</number>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>113</congress>
        <latestAction>
          <actionDate>2013-06-13</actionDate>
          <text>Became Public Law No: 113-14.</text>
        </latestAction>
        <latestTitle>Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013</latestTitle>
        <type>S</type>
      </item>
    </relatedBills>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <updateDate>2016-10-25T16:01:40Z</updateDate>
    <cosponsors>
      <item>
        <middleName>M.</middleName>
        <firstName>JOHN</firstName>
        <identifiers>
          <lisID>1527</lisID>
          <bioguideId>S000364</bioguideId>
          <gpoId>7939</gpoId>
        </identifiers>
        <bioguideId>S000364</bioguideId>
        <fullName>Rep. Shimkus, John [R-IL-15]</fullName>
        <lastName>SHIMKUS</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName />
        <firstName>FRED</firstName>
        <identifiers>
          <gpoId>7991</gpoId>
          <lisID>1177</lisID>
          <bioguideId>U000031</bioguideId>
        </identifiers>
        <bioguideId>U000031</bioguideId>
        <fullName>Rep. Upton, Fred [R-MI-6]</fullName>
        <lastName>UPTON</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName>R.</middleName>
        <firstName>JOSEPH</firstName>
        <identifiers>
          <gpoId>8134</gpoId>
          <bioguideId>P000373</bioguideId>
          <lisID>1514</lisID>
        </identifiers>
        <bioguideId>P000373</bioguideId>
        <fullName>Rep. Pitts, Joseph R. [R-PA-16]</fullName>
        <lastName>PITTS</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName>A.</middleName>
        <firstName>HENRY</firstName>
        <identifiers>
          <gpoId>7835</gpoId>
          <lisID>1209</lisID>
          <bioguideId>W000215</bioguideId>
        </identifiers>
        <bioguideId>W000215</bioguideId>
        <fullName>Rep. Waxman, Henry A. [D-CA-33]</fullName>
        <lastName>WAXMAN</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName />
        <firstName>FRANK</firstName>
        <identifiers>
          <bioguideId>P000034</bioguideId>
          <lisID>887</lisID>
          <gpoId>8048</gpoId>
        </identifiers>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <lastName>PALLONE</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName>C.</middleName>
        <firstName>Michael</firstName>
        <identifiers>
          <lisID>1751</lisID>
          <bioguideId>B001248</bioguideId>
          <gpoId>8182</gpoId>
        </identifiers>
        <bioguideId>B001248</bioguideId>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <lastName>Burgess</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName />
        <firstName>Brett</firstName>
        <identifiers>
          <lisID>1922</lisID>
          <bioguideId>G000558</bioguideId>
          <gpoId>7954</gpoId>
        </identifiers>
        <bioguideId>G000558</bioguideId>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <lastName>Guthrie</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <middleName />
        <firstName>Adam</firstName>
        <identifiers>
          <bioguideId>K000378</bioguideId>
          <lisID>2014</lisID>
          <gpoId>7931</gpoId>
        </identifiers>
        <bioguideId>K000378</bioguideId>
        <fullName>Rep. Kinzinger, Adam [R-IL-16]</fullName>
        <lastName>Kinzinger</lastName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2013-04-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates />
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2013-04-12</actionDate>
      <links />
    </latestAction>
    <committeeReports />
    <title>Animal Generic Drug User Fee Amendments of 2013</title>
    <amendments />
    <laws />
    <billNumber>1408</billNumber>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

